Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of iron deficiency anemia
3.2.1.2 Increasing awareness towards timely diagnosis
3.2.1.3 Advancements in treatment options
3.2.1.4 Growing geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of advanced therapies
3.2.2.2 Availability of alternative treatment options
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Oral iron
5.3 Intravenous (IV) iron
Chapter 6 Market Estimates and Forecast, By Therapy Areas, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Inflammatory bowel disease
6.3 Renal
6.4 Obstetrics and gynecology
6.5 Congestive heart failure (CHF)
6.6 Oncology
6.7 Other therapy areas
Chapter 7 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Adults
7.3 Pediatric
7.4 Geriatric
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 AbbVie Inc.
10.3 AdvaCare Pharma
10.4 Akebia Therapeutics, Inc.
10.5 Bayer AG
10.6 Covis Pharma GmbH
10.7 CSL Limited
10.8 F. Hoffmann-La Roche Ltd.
10.9 GSK plc
10.10 Johnson & Johnson
10.11 Novartis AG
10.12 PHARMACOSMOS A/S
10.13 Pfizer Inc.
10.14 Sanofi
10.15 SK Capital Partners
10.16 Zydus Lifesciences Limited
